Clinical Trials Browser

Not yet recruiting × NETWORK × Interventional × Clear all

NCT07278739 2026-04-16

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

Phase NA Not yet recruiting

Other solid neoplasm

Malignant Solid Neoplasm

NCT07530679 2026-04-15

Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination

Phase NA Not yet recruiting

Cervical Cancer Prevention

NCT07297667 2026-04-13

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Phase 1 Not yet recruiting

BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT07498465 2026-03-27

A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07203053 2026-03-25

START-lung

Phase 2 Not yet recruiting

Extensive Stage Lung Small Cell Cancer

NCT07341191 2026-03-25

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

Phase 2 Not yet recruiting

Recurrence, Lymphoma, Mantle-Cell

NCT06858501 2026-03-19

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Phase 2 Not yet recruiting

Ganglioneuroblastoma

NCT07466316 2026-03-12

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

Phase 3 Not yet recruiting

Rhabdomyosarcoma

NCT07022678 2026-02-27

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07425808 2026-02-23

FIT-AML

Phase 2/3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06972615 2026-02-17

Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT07393555 2026-02-06

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Phase 3 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT05411237 2026-01-23

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

Phase 3 Not yet recruiting

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05797662 2026-01-23

A Study of Propranolol to Treat Kaposi Sarcoma

Phase 2 Not yet recruiting

Sarcoma, Kaposi

NCT07347977 2026-01-16

LidCRM

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT07072585 2025-12-31

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Phase 2/3 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07234877 2025-11-19

A Randomized Phase II Study Evaluating Upfront SRT to All Brain Metastases Followed by Ivonescimab Plus Chemotherapy Versus Upfront Ivonescimab Plus Chemotherapy in Patients With Asymptomatic Active Brain Metastases From NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07068074 2025-11-13

A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

Phase 3 Not yet recruiting

Melanoma

NCT07085728 2025-08-22

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

Phase 2 Not yet recruiting

Multiple Myeloma

NCT07122492 2025-08-14

FoRtitude

Phase NA Not yet recruiting

Breast Cancer Survivor

NCT07058012 2025-07-10

EMPIRE

Phase 2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

NCT07040280 2025-06-27

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

Phase 2 Not yet recruiting

Melanoma, Skin Neoplasms

NCT06978062 2025-06-05

NeoBEMA

Phase 1 Not yet recruiting

Gastrointestinal

GastroEsophageal Cancer

NCT06990061 2025-05-25

BRACE

Phase NA Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT06938490 2025-04-22

COLAP-D3

Phase NA Not yet recruiting

Gastrointestinal

Neoplasms, Colorectal Neoplasms, Anastomotic Leak

NCT06845306 2025-02-25

ICG-NIRF

Phase 3 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

NCT05944783 2025-02-12

BE-Dasatinib

Phase 4 Not yet recruiting

Multiple Myeloma

NCT06524024 2025-02-10

DC-CTL

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT06783348 2025-01-23

RENALUT

Phase 2 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

NCT06724237 2024-12-09

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Phase 3 Not yet recruiting

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

NCT06407401 2024-11-05

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

Phase 3 Not yet recruiting

Breast Neoplasms, Musculoskeletal Pain, Drug-Related Side Effects and Adverse Reactions

NCT06526897 2024-07-30

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

Phase NA Not yet recruiting

Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT06310369 2024-07-22

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05628623 2024-07-03

ERASE

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute